๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Georgetown University Hospital, Medstar Health

โœ Scribed by Timothy R. DeKlotz; Marilyn Kelly; Michael Collins; H. Jeffrey Kim


Book ID
102453263
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
268 KB
Volume
121
Category
Article
ISSN
0023-852X

No coin nor oath required. For personal study only.

โœฆ Synopsis


Objectives: To characterize the spectrum, symptoms, progression and effects of endocrine dysfunction on sinonasal disease in polyostotic fibrous dysplasia (PFD) and McCune-Albright Syndrome (MAS). Study Design: Retrospective cohort. Methods: A cohort of PFD/MAS subjects underwent a comprehensive evaluation that included otolaryngologic and endocrine evaluation, and imaging studies. Head CT scans were analyzed, and the degree of fibrous dysplasia (FD) was graded using a modified Lund-MacKay scale. Those followed for more than 4 years were analyzed for progression. Results: A total of 106 patients meeting inclusion criteria were identified with craniofacial FD. A majority (92%) demonstrated sinonasal involvement. There were significant positive correlations between the sinonasal FD scale score and chronic congestion, hyposmia, growth hormone excess and hyperthyroidism (p < 0.05 for all). Significant correlations were not found for headache/facial pain or recurrent/chronic sinusitis. Thirty-one subjects met the criteria for longitudinal analysis (follow-up mean 6.3 years, range 4.4 -9 years). Those demonstrating disease progression were significantly younger than those who did not (mean age = 11 vs. 25 years). Progression was more common in younger patients; rarely occurring after the age of 13. Concomitant endocrinopathy or bisphosphonate use did not have any significant effect on progression of disease. Conclusions: Sinonasal involvement of fibrous dysplasia in PFD/MAS is common. Symptoms are usually few and mild and disease progression occurs primarily in young subjects. Conservative management is advised with surgical intervention reserved for intolerable symptoms.


๐Ÿ“œ SIMILAR VOLUMES